Journal article
Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
Matti Lehtinen, Kevin A Ault, Erika Lyytikainen, Joakim Dillner, Suzanne M Garland, Daron G Ferris, Laura A Koutsky, Heather L Sings, Shuang Lu, Richard M Haupt, Jorma Paavonen
Sexually Transmitted Infections | BMJ PUBLISHING GROUP | Published : 2011
Grants
Funding Acknowledgements
This study was funded by Merck Sharp & Dohme, Whitehouse Station, NJ.ML, KAA, JD, SMG, DGF and LAK have received funding through their institutions to conduct HPV vaccine studies for Merck. KAA has received consultancy and advisory board fees from Merck, and has received funding through his institution to conduct HPV-related research for Roche, Gen Probe and GlaxoSmithKline. JD has received consultancy fees, lecture fees and research grants from Merck and Sanofi Pasteur MSD. SMG has received advisory board fees and grant support from Commonwealth Serum Laboratories and GlaxoSmithKline, and lecture fees from Merck. DGF has received consultancy fees and funding through his institution to conduct HPV vaccine studies for GlaxoSmithKline, and lecture fees from Merck. JP has received consultancy fees and travel grants from Merck and GlaxoSmithKline. HLS, SL and RMH are employees of Merck and potentially own stock and/or stock options in the company.